PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26089599-9	2015	In this respect, the development of clinically applicable derivatives of the palindromic compound 1,6-bis(phosphocholine)-hexane (1,6-bis PC) should be a major focus of future CRP research.	1,6-bis(phosphocholine)-hexane	98-128	C-reactive protein	Homo sapiens	176-179	
16642000-7	2006	Here we report the design, synthesis and efficacy of 1,6-bis(phosphocholine)-hexane as a specific small-molecule inhibitor of CRP.	1,6-bis(phosphocholine)-hexane	53-83	C-reactive protein	Homo sapiens	126-129	
16642000-9	2006	Administration of 1,6-bis(phosphocholine)-hexane to rats undergoing acute myocardial infarction abrogated the increase in infarct size and cardiac dysfunction produced by injection of human CRP.	1,6-bis(phosphocholine)-hexane	18-48	C-reactive protein	Homo sapiens	190-193	
29713320-9	2018	1,6-bis(phosphocholine)-hexane (1,6-bisPC), which stabilizes CRP in its native pentameric form was used to validate CRP effects.	1,6-bis(phosphocholine)-hexane	0-30	C-reactive protein	Homo sapiens	61-64	
29713320-9	2018	1,6-bis(phosphocholine)-hexane (1,6-bisPC), which stabilizes CRP in its native pentameric form was used to validate CRP effects.	1,6-bis(phosphocholine)-hexane	0-30	C-reactive protein	Homo sapiens	116-119	
29713320-9	2018	1,6-bis(phosphocholine)-hexane (1,6-bisPC), which stabilizes CRP in its native pentameric form was used to validate CRP effects.	1,6-bis(phosphocholine)-hexane	32-41	C-reactive protein	Homo sapiens	61-64	
29713320-9	2018	1,6-bis(phosphocholine)-hexane (1,6-bisPC), which stabilizes CRP in its native pentameric form was used to validate CRP effects.	1,6-bis(phosphocholine)-hexane	32-41	C-reactive protein	Homo sapiens	116-119	
29713320-14	2018	1,6-bisPC reverses these effects via inhibition of the conformational change that leads to exposure of pro-inflammatory epitopes in CRP (pCRP* and mCRP).	1,6-bis(phosphocholine)-hexane	0-9	C-reactive protein	Homo sapiens	132-135	
26089599-9	2015	In this respect, the development of clinically applicable derivatives of the palindromic compound 1,6-bis(phosphocholine)-hexane (1,6-bis PC) should be a major focus of future CRP research.	1,6-bis(phosphocholine)-hexane	130-140	C-reactive protein	Homo sapiens	176-179